[{"address1": "9237 East Via de Ventura Boulevard", "address2": "Suite 105", "city": "Scottsdale", "state": "AZ", "zip": "85258", "country": "United States", "phone": "480 434 6670", "website": "https://journeymedicalcorp.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also offers Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Exelderm for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Emrosi for the treatment of inflammatory lesions of rosacea, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.", "fullTimeEmployees": 41, "companyOfficers": [{"maxAge": 1, "name": "Dr. Lindsay Allan Rosenwald M.D.", "age": 70, "title": "Executive Chairman", "yearBorn": 1955, "fiscalYear": 2024, "totalPay": 50000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Claude  Maraoui", "age": 58, "title": "Founder, President, CEO & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 975434, "exercisedValue": 0, "unexercisedValue": 4806250}, {"maxAge": 1, "name": "Mr. Joseph M. Benesch", "age": 58, "title": "CFO & Corporate Controller", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 434088, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ramsey  Alloush", "age": 39, "title": "COO, General Counsel & Company Secretary", "yearBorn": 1986, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Nevin", "age": 56, "title": "Chief Commercial Officer", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Jaclyn  Jaffe", "title": "Senior Director of Corporate Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Louis  Donati", "title": "Director of Market Access", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 10, "compensationRisk": 7, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1769904000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.46, "open": 8.49, "dayLow": 8.44, "dayHigh": 8.799, "regularMarketPreviousClose": 8.46, "regularMarketOpen": 8.49, "regularMarketDayLow": 8.44, "regularMarketDayHigh": 8.799, "payoutRatio": 0.0, "beta": 0.819, "forwardPE": -141.66667, "volume": 128190, "regularMarketVolume": 128190, "averageVolume": 132623, "averageVolume10days": 98870, "averageDailyVolume10Day": 98870, "bid": 8.42, "ask": 8.6, "bidSize": 1, "askSize": 1, "marketCap": 282680992, "fiftyTwoWeekLow": 4.85, "fiftyTwoWeekHigh": 9.555, "allTimeHigh": 10.2, "allTimeLow": 1.02, "priceToSalesTrailing12Months": 4.7590194, "fiftyDayAverage": 8.014, "twoHundredDayAverage": 7.521075, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 231008192, "profitMargins": -0.14583999, "floatShares": 16947458, "sharesOutstanding": 27256588, "sharesShort": 2559784, "sharesShortPriorMonth": 2444447, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.077, "heldPercentInsiders": 0.24337, "heldPercentInstitutions": 0.41098, "shortRatio": 18.42, "shortPercentOfFloat": 0.1171, "impliedSharesOutstanding": 33256588, "bookValue": 0.982, "priceToBook": 8.655805, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -8663000, "trailingEps": -0.35, "forwardEps": -0.06, "enterpriseToRevenue": 3.889, "enterpriseToEbitda": -174.874, "52WeekChange": 0.503891, "SandP52WeekChange": 0.11527538, "quoteType": "EQUITY", "currentPrice": 8.5, "targetHighPrice": 16.0, "targetLowPrice": 12.0, "targetMeanPrice": 13.5, "targetMedianPrice": 13.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 24948000, "totalCashPerShare": 0.919, "ebitda": -1321000, "totalDebt": 25301000, "quickRatio": 1.081, "currentRatio": 1.42, "totalRevenue": 59399000, "debtToEquity": 97.695, "revenuePerShare": 2.577, "returnOnAssets": -0.04603, "returnOnEquity": -0.47050998, "grossProfits": 39235000, "freeCashflow": -15973875, "operatingCashflow": -3932000, "revenueGrowth": 0.205, "grossMargins": 0.66053003, "ebitdaMargins": -0.02224, "operatingMargins": -0.08672, "financialCurrency": "USD", "symbol": "DERM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "exchange": "NCM", "messageBoardId": "finmb_280596341", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.472813, "regularMarketPrice": 8.5, "corporateActions": [], "postMarketTime": 1771621474, "regularMarketTime": 1771621203, "shortName": "Journey Medical Corporation", "longName": "Journey Medical Corporation", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1636727400000, "postMarketChangePercent": 0.0, "postMarketPrice": 8.5, "postMarketChange": 0.0, "regularMarketChange": 0.04, "regularMarketDayRange": "8.44 - 8.799", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 132623, "fiftyTwoWeekLowChange": 3.65, "fiftyTwoWeekLowChangePercent": 0.75257736, "fiftyTwoWeekRange": "4.85 - 9.555", "fiftyTwoWeekHighChange": -1.0550003, "fiftyTwoWeekHighChangePercent": -0.110413425, "fiftyTwoWeekChangePercent": 50.3891, "earningsTimestampStart": 1774558800, "earningsTimestampEnd": 1774558800, "earningsCallTimestampStart": 1762983000, "earningsCallTimestampEnd": 1762983000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.35, "epsForward": -0.06, "fiftyDayAverageChange": 0.48600006, "fiftyDayAverageChangePercent": 0.06064388, "twoHundredDayAverageChange": 0.9789252, "twoHundredDayAverageChangePercent": 0.13015762, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-11-12", "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "trailingPegRatio": null, "__fetch_time": "2026-02-21"}]